US Approves 1st Stem Cell Study for Spinal Injury
NEW YORK – A U.S. biotech company says it plans to start this summer the world's first study of a treatment based on human embryonic stem cells — a long-awaited project aimed at spinal cord injury.
Friday, Nov 8, 2024
Last Update:5:00 PM EST